BMC Cancer

1. GOEL R, Alvi S, Ali R, Sharma P, et al
   Targeted paclitaxel delivery in ovarian cancer via AP1-functionalized elastin-like polypeptide nanocarriers: development and characterization.
   BMC Cancer. 2026 Jan 26. doi: 10.1186/s12885-026-15615.
   

   >> Share

   
   

   
   Cancer

2. O'CONNELL CP, Berndt SI, Chudy-Onwugaje K, Kunzmann A, et al
   Association of alcohol intake over the lifetime with colorectal adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
   Cancer. 2026;132:e70201.
   

   >> Share

   
   

   
   Clin Cancer Res

3. CHO HW, Park JY, Lim MC, Kim BG, et al
   Maintenance of PARP Inhibitor Rechallenge Plus Bevacizumab in Patients with Platinum-Sensitive, Recurrent Ovarian Cancer Previously Treated with a PARP Inhibitor.
   Clin Cancer Res. 2026 Jan 29. doi: 10.1158/1078-0432.CCR-25-2916.
   

   >> Share

   
   

   
   Eur J Obstet Gynecol Reprod Biol

4. GAO X, Jiang X, Chen J, Du B, et al
   Association between cardiometabolic index and prevalence of ovarian cancer among US adults: A cross-sectional NHANES study.
   Eur J Obstet Gynecol Reprod Biol. 2026;319:114954.
   

   >> Share

   
   

   
   Int J Cancer

5. REDL E, Herzog C, Vavourakis C, Barrett J, et al
   The cervico-vaginal DNA methylation WID-qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer.
   Int J Cancer. 2026 Jan 29. doi: 10.1002/ijc.70354.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share